APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 65 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,000 | -30.8% | 3,000 | -25.0% | 0.01% | -53.8% |
| Q1 2020 | $13,000 | -43.5% | 4,000 | -20.0% | 0.01% | -23.5% |
| Q4 2019 | $23,000 | +53.3% | 5,000 | +38.9% | 0.02% | +41.7% |
| Q3 2019 | $15,000 | +7.1% | 3,600 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $14,000 | -6.7% | 3,600 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $15,000 | +66.7% | 3,600 | 0.0% | 0.01% | +40.0% |
| Q4 2018 | $9,000 | -65.4% | 3,600 | 0.0% | 0.01% | -52.4% |
| Q3 2018 | $26,000 | +73.3% | 3,600 | -10.0% | 0.02% | +61.5% |
| Q2 2018 | $15,000 | 0.0% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $15,000 | +7.1% | 4,000 | 0.0% | 0.01% | +8.3% |
| Q4 2017 | $14,000 | -12.5% | 4,000 | 0.0% | 0.01% | -7.7% |
| Q3 2017 | $16,000 | +60.0% | 4,000 | +100.0% | 0.01% | +44.4% |
| Q2 2017 | $10,000 | +233.3% | 2,000 | +400.0% | 0.01% | +200.0% |
| Q1 2017 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |